The effect of probiotic therapy on quality of life and depressive symptoms in patients with diarrhea-predominant irritable bowel syndrome

dc.authorid0000-0002-8293-3554
dc.contributor.authorYiğit, Ece
dc.date.accessioned2023-06-13T08:34:26Z
dc.date.available2023-06-13T08:34:26Z
dc.date.issued2023
dc.departmentİstanbul Medipol Üniversitesi, Tıp Fakültesi, Dahili Tıp Bilimleri Bölümü, İç Hastalıkları Ana Bilim Dalı
dc.description.abstractAim: The aim of this study was to analyze the effect of probiotics on quality of life and depressive symptoms in patients with diarrhea-predominant irritable bowel syndrome (IBS) and moderate or severe depressive mood. Materials and Methods: Patients diagnosed with diarrhea-predominant IBS using the Rome IV criteria and Bristol Stool Form Scale and with moderate or severe depressive symptoms according to the Beck Depression Inventory comprised the study participants. The patients were randomized and divided into two groups as the medication only group and the medication + probiotic group. The IBS 36 questionnaire and Beck’s Depression Inventory were administered to all patients in the first and second groups and the scores were recorded. Results: The change in IBS-36 scores from the beginning to the 10th week was significant in both groups (p<0.001). According to the IBS-36, the median change from the beginning to the 10th week was 32 for the medication group and 48 for the medication + probiotic group. The change in the Beck’s Depression Inventory scores from the beginning to the 10th week was significant in both the medication group and the medication + probiotic group (p<0.001). According to the Beck’s Depression Inventory, the median change from the beginning to the 10th week was 7 for the medication group and 9.5 for the medication + probiotic group. Conclusion: In the treatment of diarrhea-predominant IBS patients, the use of probiotics together with traditional drugs will improve quality of life by reducing both gastrointestinal symptoms and psychological symptoms.
dc.identifier.citationYiğit, E. (2023). The effect of probiotic therapy on quality of life and depressive symptoms in patients with diarrhea-predominant irritable bowel syndrome. Annals of Medical Research, 30(4), 434-439. https://doi.org/10.5455/annalsmedres.2022.10.316
dc.identifier.doi10.5455/annalsmedres.2022.10.316
dc.identifier.endpage439
dc.identifier.issn2636-7688
dc.identifier.issue4
dc.identifier.startpage434
dc.identifier.trdizinid1164949
dc.identifier.urihttps://doi.org/10.5455/annalsmedres.2022.10.316
dc.identifier.urihttps://hdl.handle.net/20.500.12511/11075
dc.identifier.volume30
dc.indekslendigikaynakTR-Dizin
dc.institutionauthorYiğit, Ece
dc.language.isoen
dc.publisherInönü University Faculty of Medicine
dc.relation.ispartofAnnals of Medical Researchen_US
dc.relation.publicationcategoryMakale - Ulusal Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International*
dc.rightsinfo:eu-repo/semantics/openAccess
dc.rights.urihttps://creativecommons.org/licenses/by-nc-nd/4.0/*
dc.subjectIrritable Bowel Syndrome
dc.subjectDiarrhea
dc.subjectProbiotics
dc.subjectDepression
dc.titleThe effect of probiotic therapy on quality of life and depressive symptoms in patients with diarrhea-predominant irritable bowel syndrome
dc.typeArticle

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Yükleniyor...
Küçük Resim
İsim:
Yigit-Ece-2023.pdf
Boyut:
728.81 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Tam Metin / Full Text
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.44 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama: